These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Intratympanic gentamicin treatment of patients with Ménière's disease with normal hearing. Silverstein H; Wazen J; Van Ess MJ; Daugherty J; Alameda YA Otolaryngol Head Neck Surg; 2010 Apr; 142(4):570-5. PubMed ID: 20304280 [TBL] [Abstract][Full Text] [Related]
6. Low-dose intratympanic gentamicin and the treatment of Meniere's disease: preliminary results. Driscoll CL; Kasperbauer JL; Facer GW; Harner SG; Beatty CW Laryngoscope; 1997 Jan; 107(1):83-9. PubMed ID: 9001270 [TBL] [Abstract][Full Text] [Related]
7. Outcomes of endolymphatic shunt surgery for Ménière's disease: comparison with intratympanic gentamicin on vertigo control and hearing loss. Derebery MJ; Fisher LM; Berliner K; Chung J; Green K Otol Neurotol; 2010 Jun; 31(4):649-55. PubMed ID: 20431498 [TBL] [Abstract][Full Text] [Related]
13. Long-term vertigo control in patients after intratympanic gentamicin instillation for Ménière's disease. Bodmer D; Morong S; Stewart C; Alexander A; Chen JM; Nedzelski JM Otol Neurotol; 2007 Dec; 28(8):1140-4. PubMed ID: 18084826 [TBL] [Abstract][Full Text] [Related]
14. Treatment of Ménière's disease with "on-demand" intratympanic gentamicin injections. Manrique-Huarte R; Guillén-Grima F; Perez-Fernandez N Otol Neurotol; 2011 Apr; 32(3):461-5. PubMed ID: 21317673 [TBL] [Abstract][Full Text] [Related]
15. The effect of intratympanic gentamicin for treatment of Ménière's disease on lower frequency hearing. Sam G; Chung DW; van der Hoeven R; Verweij S; Becker M Int J Clin Pharm; 2016 Aug; 38(4):780-3. PubMed ID: 27073077 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of Intratympanic Gentamicin in Menière's Disease With and Without Migraine. Liu YF; Renk E; Rauch SD; Xu HX Otol Neurotol; 2017 Aug; 38(7):1005-1009. PubMed ID: 28538472 [TBL] [Abstract][Full Text] [Related]
17. [Long-term results of transtympanic gentamicin treatment in Meniere's disease]. Pierchała K; Krzeska-Malinowska I; Kowalska M; Bartoszewicz R; Niemczyk K Otolaryngol Pol; 2005; 59(3):409-13. PubMed ID: 16117399 [TBL] [Abstract][Full Text] [Related]
18. Factors relating to the vertigo control and hearing changes following intratympanic gentamicin for intractable Ménière's disease. Horii A; Saika T; Uno A; Nishiike S; Mitani K; Nishimura M; Kitahara T; Fukushima M; Nakagawa A; Masumura C; Sasaki T; Kizawa K; Kubo T Otol Neurotol; 2006 Sep; 27(6):896-900. PubMed ID: 16788414 [TBL] [Abstract][Full Text] [Related]
19. Distortion product otoacoustic emissions after intratympanic gentamicin therapy for unilateral Ménière's disease. Perez N; Boleas MS; Martin E Audiol Neurootol; 2005; 10(2):69-78. PubMed ID: 15650298 [TBL] [Abstract][Full Text] [Related]